22098853|mri|C0024485^C1824234|start=1|end=4|PROC^GENE
22098853|breast cancer screening|C0281182|start=9|end=32|PROC
22098853|mri|C0024485^C1824234|start=33|end=36|PROC^GENE
22098853|screening|C1710031^C0220909^C0220908^C1305399^C0199230^C1698960^C1710477|start=61|end=70|PROC^CONC
22098853|women|C1552469|start=71|end=76|OBJC^ORGA
22098853|increased|C0442805^C0205217|start=88|end=97|CONC
22098853|risk of|C0035647|start=98|end=105|CONC
22098853|breast cancer|C0006142^C0678222|start=106|end=119|DISO
22098853|treatment selection|C0086965|start=128|end=147|PROC
22098853|prospective studies|C0033522|start=149|end=168|PROC
22098853|confirm|C1456348^C0521093^C0750484|start=169|end=176|CONC
22098853|mri|C0024485^C1824234|start=182|end=185|PROC^GENE
22098853|screening|C1710031^C0220909^C0220908^C1305399^C0199230^C1698960^C1710477|start=186|end=195|PROC^CONC
22098853|women|C1552469|start=199|end=204|OBJC^ORGA
22098853|known|C0205309|start=210|end=215|CONC
22098853|suspected|C0750491|start=219|end=228|CONC
22098853|genetic mutation|C0026882|start=229|end=245|PHYS
22098853|sensitivity|C2349185^C1522640^C1511883^C2346484^C0036667^C0312418|start=266|end=277|PHEN^PHYS^CONC
22098853|cancer detection|C1516193|start=282|end=298|PROC
22098853|mammography|C0024671^C1552448|start=309|end=320|PROC^OBJC^ORGA
22098853|survival|C0038952^C0220921|start=331|end=339|ACTI^CONC
22098853|data|C3245479^C1511726|start=340|end=344|DEVI^CONC
22098853|not available|C1548671|start=349|end=362|CONC
22098853|women|C1552469|start=367|end=372|OBJC^ORGA
22098853|breast cancer|C0006142^C0678222|start=378|end=391|DISO
22098853|mri|C0024485^C1824234|start=393|end=396|PROC^GENE
22098853|cancer|C0006826^C1547140^C1306459^C2707253|start=405|end=411|DISO^OCCU^PHYS
22098853|not identified|C1709276|start=412|end=426|CONC
22098853|types|C0332307|start=438|end=443|CONC
22098853|screening|C1710031^C0220909^C0220908^C1305399^C0199230^C1698960^C1710477|start=447|end=456|PROC^CONC
22098853|increased sensitivity|C1881189^C2346484|start=489|end=510|PHEN
22098853|translate|C0040710|start=519|end=528|ACTI
22098853|improved|C0184511^C1561611^C0332272|start=534|end=542|CONC
22098853|selection|C1707391^C0036576|start=543|end=552|PHYS^ACTI
22098853|surgical treatment|C0543467|start=556|end=574|PROC
22098853|reduction|C0301630^C0392756^C0441610|start=580|end=589|PROC^PHEN^CONC
22098853|number|C1554106^C0449788^C0237753|start=597|end=603|CONC
22098853|operations|C3244305^C3244306^C0038895|start=607|end=617|CONC
22098853|data|C3245479^C1511726|start=619|end=623|DEVI^CONC
22098853|ipsilateral|C0441989|start=657|end=668|CONC
22098853|breast tumour|C1458155|start=669|end=682|DISO
22098853|recurrence|C1458156^C0034897^C2825055|start=683|end=693|DISO^PHEN
22098853|contralateral breast cancer|C1096616|start=704|end=731|DISO
22098853|incidence|C0220856^C0021149|start=732|end=741|CONC
22098853|date|C1547350^C1548309^C2348077^C0011008|start=761|end=765|OBJC^CONC
22098853|show|C1547282|start=773|end=777|CONC
22098853|clear|C1550016^C2963144|start=778|end=783|CONC
22098853|benefit|C0814225|start=784|end=791|CONC
22098853|mri|C0024485^C1824234|start=796|end=799|PROC^GENE
22098853|mri|C0024485^C1824234|start=801|end=804|PROC^GENE
22098853|better|C1550462^C0332272|start=808|end=814|CONC
22098853|methods|C0025664^C0449851^C0025663|start=826|end=833|CONC
22098853|response|C2911692^C1706817^C0871261|start=851|end=859|PHYS^CONC
22098853|neoadjuvant|C0600558|start=863|end=874|PROC
22098853|chemotherapy|C0392920^C3665472^C0013217|start=875|end=887|PROC^CONC
22098853|primary|C0205225^C0439631|start=923|end=930|PROC^CONC
22098853|tumour|C0027651|start=931|end=937|DISO
22098853|present|C0150312^C0449450|start=954|end=961|CONC
22098853|axillary adenopathy|C0578735|start=967|end=986|DISO
